Admission and introduction to exchange trading of series R ordinary bearer shares

Current report no. 26/2024

Drafting date: 12 August 2024.

Subject: Admission and introduction to exchange trading of series R ordinary bearer shares

Legal basis: Article 56(1)(2) of the Act on Offering - current and periodic information

The Management Board of Captor Therapeutics S.A., with its registered office in Wrocław (the "Company"), has learned that the Management Board of the Warsaw Stock Exchange adopted Resolution No. 1023/2024 of 9 August 2024 on the admission and introduction of 17,134 series R ordinary bearer shares, with a nominal value of PLN 0.10 each, to trading on the main market on 14 August 2024.

The introduction is subject to the registration of these shares by the National Depository for Securities (Krajowy Depozyt Papierów Wartościowych S.A.) on 14 August 2024 and their designation with ISIN code PLCPTRT00014.

The resolution came into force on the date of its adoption.